LIMINAL BIOSCIENCES
Liminal BioSciences is a biopharmaceutical corporation supplying state-of-the-art technologies for bio-separations as well as therapeutic products. It specializes in discovering, developing, and commercializing novel small molecule compounds for respiratory, liver, and renal diseases. The company focuses specifically on developing solutions for rare and orphan diseases. Liminal BioSciences was founded in 1992 and is headquartered in Laval, Quebec.
LIMINAL BIOSCIENCES
Industry:
Biotechnology Health Diagnostics Medical
Founded:
1992-01-01
Address:
Laval, Quebec, Canada
Country:
Canada
Website Url:
http://www.liminalbiosciences.com
Total Employee:
251+
Status:
Active
Contact:
1(450)781-0115
Total Funding:
147.81 M USD
Technology used in webpage:
SSL By Default LetsEncrypt Nginx Euro Amazon Google Maps COVID-19 Amazon Virginia Region DigiCert SSL IIS 10
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Current Advisors List
Board_member
Board_member
Board_member
Board_member
Board_member
Board_member
Board_member
Board_member
Current Employees Featured
Bruce Pritchard COO - International @ Liminal BioSciences
COO - International
2014-08-01
Kenneth Galbraith CEO @ Liminal BioSciences
CEO
Patrick Sartore Chief Legal Officer & Corporate Secretary @ Liminal BioSciences
Chief Legal Officer & Corporate Secretary
Patrick Sartore President @ Liminal BioSciences
President
2020-11-01
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2020-07-17 | Fairhaven Pharmaceuticals | Fairhaven Pharmaceuticals acquired by Liminal BioSciences | 8 M USD |
2016-08-24 | Telesta Therapeutics | Telesta Therapeutics acquired by Liminal BioSciences | N/A |
2008-09-04 | Pathogen Removal and Diagnostic Technologies | Pathogen Removal and Diagnostic Technologies acquired by Liminal BioSciences | N/A |
Investors List
National Bank Financial
National Bank Financial investment in Private Equity Round - Liminal BioSciences
Beacon Securities
Beacon Securities investment in Private Equity Round - Liminal BioSciences
Scotiabank
Scotiabank investment in Private Equity Round - Liminal BioSciences
RBC Capital Markets
RBC Capital Markets investment in Private Equity Round - Liminal BioSciences
Paradigm Capital
Paradigm Capital investment in Private Equity Round - Liminal BioSciences
CIBC World Markets
CIBC World Markets investment in Private Equity Round - Liminal BioSciences
Canaccord Genuity Group
Canaccord Genuity Group investment in Private Equity Round - Liminal BioSciences
Jefferies
Jefferies investment in Post-IPO Debt - Liminal BioSciences
Thomvest Ventures
Thomvest Ventures investment in Post-IPO Debt - Liminal BioSciences
Thomvest Ventures
Thomvest Ventures investment in Post-IPO Equity - Liminal BioSciences
Newest Events participated




Official Site Inspections
http://www.liminalbiosciences.com Semrush global rank: 6.9 M Semrush visits lastest month: 705
- Host name: ip253.ip-54-38-212.eu
- IP address: 54.38.212.253
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London

More informations about "Liminal BioSciences"
Liminal BioSciences - About Us
Liminal BioSciences is a development-stage biopharmaceutical company focused on discovering and developing novel and distinctive small molecule therapeutics that modulate G protein …See details»
Meet the Management Team - Liminal BioSciences
Bruce was appointed as Chief Executive Officer, effective 13 November 2020. Prior to that he was one of 2 Chief Operating Officers In this role he was responsible for the company’s discovery, …See details»
Liminal BioSciences - Wikipedia
Liminal [3] was founded in 1988, as a commercial spinoff of research at the University of Cambridge on affinity chromatography. [4] Its founder was the current President and CEO, …See details»
LIMINAL BIOSCIENCES ANNOUNCES COMPLETION OF …
Sep 26, 2023 Organization Profile. Liminal BioSciences Inc. Liminal BioSciences Inc. (https://liminalbiosciences.com) is a global biotechnology company that specialises in discovering, developing and ...See details»
Liminal BioSciences - LinkedIn
Liminal BioSciences is a development-stage biopharmaceutical company focused on the discovery and development of novel distinctive small molecule therapeutics that modulate G protein-coupled ...See details»
Liminal BioSciences Overview | SignalHire Company Profile
Organization Website: liminalbiosciences.com : Social Links: Phone Number +1 450 781 0115: Liminal BioSciences industries Biotech: Headquarters Location: 440 Boulevard Armand …See details»
Liminal BioSciences - Crunchbase Company Profile
Liminal is a biopharmaceutical corporation supplying state-of-the-art technologies for bio-separations as well as therapeutic products.See details»
Liminal Biosciences Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Liminal Biosciences Inc. of Laval, QC. Get the latest business insights from Dun & Bradstreet.See details»
Liminal Biosciences 2025 Company Profile: Valuation, …
Www.liminalbiosciences.com. Formerly Known As. ProMetic Life Sciences. Ownership Status. Privately Held (backing) Financing Status. Private Equity-Backed. Corporate Office. 440 Armand-Frappier Boulevard; Suite 300; Laval, …See details»
Prometic Shareholders Approve Name Change to Liminal
Oct 3, 2019 The Company's new website at www.liminalbiosciences.com will be launched concurrently. ... Organization Profile. ProMetic Life Sciences Inc. ABOUT PROMETIC LIFE …See details»
Our Strategy - Liminal BioSciences
Inspired by the opportunity to impact lives, we are committed to excellence, innovation, and scientific rigor in the high-quality research and clinical development of novel medicines to …See details»
Liminal Biosciences - Amorchem
Liminal Biosciences. Liminal Biosciences Inc. (www.liminalbiosciences.com) is a preclinical-stage biopharmaceutical company that recently acquired AmorChem’s spin-out company Fairhaven …See details»
Liminal BioSciences - Products, Competitors, Financials, Employees ...
Liminal Biosciences operates a clinical-stage biopharmaceutical company that focuses on discovering, developing, and commercializing novel treatments for patients suffering from …See details»
Member profile: Liminal BioSciences | BIA - BioIndustry
Liminal BioSciences is a development-stage biopharmaceutical company focused on the discovery and development of novel distinctive small molecule therapeutics that modulate G …See details»
Liminal Biosciences Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Liminal Biosciences Inc. of Laval, QC. Get the latest business insights from Dun & Bradstreet.See details»
Liminal BioSciences - Craft
Liminal BioSciences has 5 employees across 2 locations and $416 k in annual revenue in FY 2022. See insights on Liminal BioSciences including office locations, competitors, revenue, …See details»
Liminal BioSciences - LinkedIn
Liminal BioSciences | 8,044 followers on LinkedIn. Liminal BioSciences is a development-stage biopharmaceutical company focused on the discovery and development of novel distinctive …See details»
Liminal BioSciences Enters into Agreement with Kedrion to
May 17, 2021 Organization Profile. Liminal BioSciences Inc. Liminal BioSciences Inc. (https://liminalbiosciences.com) is a global biotechnology company that specialises in …See details»
Liminal BioSciences - Overview, News & Similar companies
Sep 26, 2023 LIMINAL BIOSCIENCES ANNOUNCES COMPLETION OF THE PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP LAVAL, QC and CAMBRIDGE, England, …See details»
Establishing Canada’s first large-scale bioinnovation centre
2 days ago The Neptune BioInnovation Centre (NBC), a 51,000 sq ft facility on a 12.3 acre lot in Dartmouth, will offer leasable wet and dry lab space, warehouse and office spaces, and …See details»